Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsJeffrey Dover, MD
Associate Clinical ProfessorAbout
Research
Publications
2026
Development of a Core Outcome Domain Set for Facial Aging.
Dirr M, Ahmed A, Schlessinger D, Lazaro-Camp V, Smith S, Gullapalli T, Dragovic D, Chang J, Zhang E, Alam M, Anvery N, Christensen R, Ibrahim S, Kang B, Wong C, Iyengar S, Yanes A, Cotseones J, Ashchyan H, Patel P, Sheikh U, Franklin M, Hanna C, Chiren S, Schmitt J, Furlan K, Alexiades M, Alhusayen R, Alster T, Beer K, Bertucci V, Bloom J, Briceño C, Bucay V, Butterwick K, Hugues C, Casabona G, Connolly K, Cotofana S, Council M, Cox S, Darmanescu M, De Boulle K, Desai S, Donofrio L, Dover J, Draelos Z, Eisen D, El-Domyati M, El-Garem Y, Fischer J, Fitzgerald R, Friedmann D, Galadari H, Gladstone H, Goldman M, Goodman G, Green J, Halachmi S, Hanke C, Humphrey S, Ibrahim S, Jagdeo J, Jiang S, Karen J, Kauvar A, Kibbi A, Kim J, Kim J, de Lacerda D, Lask G, Lopez G, Lupo M, Mariwalla K, Matarasso S, Mekokishvili L, Narins R, Ogilvie P, Orringer J, Osaki T, Ozog D, Pacheco T, Polder K, Rossi A, Sadick N, Saedi N, Schlessinger J, Sharad J, Shenoy M, Sinclair R, Solish N, Piansay-Soriano M, Sulyman O, Szeimies R, Tanzi E, Taub A, Taylor M, Thomas J, Torezan L, Tosti A, Touma D, Trindade de Almeida A, Vedamurthy M, Viana G, Waldman A, Weinkle S, Weiss R, Poon E, Maher I, Cartee T, Sobanko J, Kirkham J. Development of a Core Outcome Domain Set for Facial Aging. JAMA Dermatology 2026 PMID: 42307924, DOI: 10.1001/jamadermatol.2026.1697.Peer-Reviewed Original ResearchCore outcome setOutcome domainsClinical trialsCochrane Central RegisterCore outcome domain setAdverse eventsFacial agingSystemic adverse eventsCochrane Central Register of Controlled TrialsCentral Register of Controlled TrialsReturn to normal workEfficacy of interventionsDuration of treatment effectRegister of Controlled TrialsConvenience of treatmentControlled clinical trialsRandomized clinical trialsPhysician stakeholdersOutcome setPatient interviewsDelphi surveyDelphi consensusPigmentary changesPatient satisfactionConsensus meetingLasers and Acquired Melanocytic Nevi: A Systematic Review.
Levoska M, Paragh L, Levinson C, Dover J, Labadie J. Lasers and Acquired Melanocytic Nevi: A Systematic Review. Dermatologic Surgery 2026 PMID: 42233715, DOI: 10.1097/dss.0000000000005200.Peer-Reviewed Original ResearchRestorative cosmetic dermatology: Utilizing cosmetic procedures to correct appearance and function in patients with medical dermatologic conditions – Part II. Condition-specific applications
Kang B, Alam M, Dover J. Restorative cosmetic dermatology: Utilizing cosmetic procedures to correct appearance and function in patients with medical dermatologic conditions – Part II. Condition-specific applications. Journal Of The American Academy Of Dermatology 2026 PMID: 42092607, DOI: 10.1016/j.jaad.2026.03.119.Peer-Reviewed Original ResearchRestorative cosmetic dermatology: Utilizing cosmetic procedures to correct appearance and function in patients with medical dermatologic conditions – Part I. Principles of restorative cosmetic dermatology & core techniques
Kang B, Alam M, Dover J. Restorative cosmetic dermatology: Utilizing cosmetic procedures to correct appearance and function in patients with medical dermatologic conditions – Part I. Principles of restorative cosmetic dermatology & core techniques. Journal Of The American Academy Of Dermatology 2026 PMID: 42092610, DOI: 10.1016/j.jaad.2026.04.1983.Peer-Reviewed Original ResearchMedical dermatology conditionsQuality of lifeHigh-risk populationPhysical functionApproach to patient evaluationPatient confidenceProcedural risk factorsCosmetic dermatologyCounseling patientsLong-term recoveryMedical dermatologyRisk factorsPatient evaluationPatient counselingPsychosocial impairmentSkin integrityMultidisciplinary settingPost-procedural careDisease activityThoughtful applicationTreatment planningCounselingPatientsClinical implementationDermatological conditions
2025
Comparing ChatGPT Informed Consent Documentations for Energy‐Based Devices
Kim L, Rajanala S, Dover J, Labadie J. Comparing ChatGPT Informed Consent Documentations for Energy‐Based Devices. Lasers In Surgery And Medicine 2025, 58: 21-25. PMID: 41339661, DOI: 10.1002/lsm.70080.Peer-Reviewed Original ResearchSafe and effective acne treatment across skin types with a 1726 nm sebum-selective laser: One year data from a prospective multicenter study
Goldberg D, Ronan S, Bhatia A, Dhawan S, Green J, Kilmer S, Kwan W, Stein Gold L, Weiss J, Doucette M, Karavitis M, Dover J. Safe and effective acne treatment across skin types with a 1726 nm sebum-selective laser: One year data from a prospective multicenter study. Journal Of The American Academy Of Dermatology 2025, 94: 517-524. PMID: 41052654, DOI: 10.1016/j.jaad.2025.09.077.Peer-Reviewed Original ResearchInvestigator's Global Assessment scoreModerate-to-severe acneInflammatory lesion countGlobal assessment scoreLesion countsProspective institutional review board-approved studyInstitutional review board-approved studyReview board-approved studySkin types II-VIProspective multicenter studyOpen-label designProportion of patientsBoard-approved studyEffective acne treatmentAssessment scoresFollow-up dataOne-year follow-up dataFollow-up timepointsFacial acneMild erythemaMulticenter studyProspective studyAdverse eventsNo control groupAcne treatmentTreatment of Melasma Using Low-Fluence QS Nd: YAG (1064 nm) Laser: A Blind, Randomized, Placebo-Controlled Trial
Sadeghpour M, Laughter M, Rizzo S, Depina J, Petrell K, Arndt K, Dover J. Treatment of Melasma Using Low-Fluence QS Nd: YAG (1064 nm) Laser: A Blind, Randomized, Placebo-Controlled Trial. Dermatologic Surgery 2025, 52: 205-211. PMID: 40932145, DOI: 10.1097/dss.0000000000004846.Peer-Reviewed Original ResearchTreatment of melasmaHydroquinone 4%Patient-reported improvementQS-NdMelanin indexFitzpatrick skin types I-IVSkin types I-IVQS Nd:YAG laserPlacebo-controlled trialLaser treatment groupMelasma severity scoreSplit face trialStatistically significant differenceMMASI scoreTopical therapyPlacebo-ControlledTypes I-IVMonths treatmentFollow-upInadequately controlled studiesWeek 8Severity scoreTreatment protocolsMelasmaTreatment groupsLasers and Energy-Based Devices for Treatment of Pigmented Lesions With Histologic and Ultrastructural Imaging Correlation: A Systematic Review
Lee M, Al Janahi S, Dover J, Kelly K, Chung H. Lasers and Energy-Based Devices for Treatment of Pigmented Lesions With Histologic and Ultrastructural Imaging Correlation: A Systematic Review. Dermatologic Surgery 2025, 52: 239-246. PMID: 40767860, DOI: 10.1097/dss.0000000000004803.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsReflectance confocal microscopyPigmented lesionsOptical coherence tomography findingsCafe-au-lait maculesSystematic reviewElongated rete ridgesLight microscopyConfocal microscopyEnergy-based devicesTomography findingsAggressive treatmentTreatment of pigmented lesionsImaging findingsPoor outcomePostinflammatory hyperpigmentationPicosecond laserLesionsRete ridgesNanosecond laserLesion baseUltrastructural changesTreatmentLaser toningEfficacyPicosecondsCurrent Trends and Future Directions of the Dual 1550‐nm Erbium Glass Fiber and 1927‐nm Thulium Fiber Non‐Ablative Fractional Laser System
Friedman P, Dover J, Chapas A, Jacobson A. Current Trends and Future Directions of the Dual 1550‐nm Erbium Glass Fiber and 1927‐nm Thulium Fiber Non‐Ablative Fractional Laser System. Lasers In Surgery And Medicine 2025, 57: 561-570. PMID: 40635144, DOI: 10.1002/lsm.70043.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsMechanism of actionSystemic mechanism of actionExpert consensusPersonalized treatment approachesFitzpatrick skin typeFractional laser systemActinic keratosesSafety profilePigmented lesionsTreatment approachesEsthetic medicineSkin concernsSkin typeSkin conditionsStandard protocolLaser systemDyschromiaSkin agingConsensus Statement on the Prevention and Management of Complications of Fully Ablative Laser Resurfacing of the Face
Kang B, Cohen J, Geronemus R, Kilmer S, Ross E, Tanzi E, Waibel J, Wong B, Alam M, Alexiades M, Arndt K, Avram M, Bhatia A, Biesman B, Bloom J, Burns A, Chan H, DiGiorgio C, Dover J, Fathizadeh S, Esteves S, Gold M, Goldberg G, Haedersdal M, Hoss E, Ibrahimi O, Jalian H, Kelly K, Manuskiatti W, Marks L, Munavalli G, Pozner J, Robb C, Rossi A, Saedi N, Shumaker P, Stankiewicz K, Wanner M, Wu D, Wulkan A, Ortiz A. Consensus Statement on the Prevention and Management of Complications of Fully Ablative Laser Resurfacing of the Face. Lasers In Surgery And Medicine 2025, 57: 477-489. PMID: 40495549, DOI: 10.1002/lsm.70035.Peer-Reviewed Original ResearchAblative laser resurfacingLaser resurfacingAdverse eventsPostoperative careConsensus statementPlastic surgeryManagement of adverse eventsContraindications to treatmentManagement of infectionsConsensus meetingManagement of complicationsExpert clinical experienceManagement of scarsInternational consensus statementFacial plastic surgeryIntraoperative precautionsPatient selectionOculoplastic surgerySurgeryClinical experiencePreoperative careLaser surgeonVirtual consensus meetingSystematic reviewDraft statement